US Capital Chosen As Advisor On A Large Capital Raise By A Company Behind Silver-Cannabinoid Formula Against Drug-Resistant Infections

US Capital has been engaged by Andira Pharmaceuticals as its strategic advisor on a multi-million dollar capital raise round. Andira is a privately held woman-led health science company, developing therapeutics including its Matrix3 anti-infective technology for wound care, which has the potential to deliver protection against dangerous, drug-resistant bacterial infections.

The company is also developing injectable therapy for hospital acquired infections such as VRE and MRSA, as well as new treatments for breast cancer, with a focus on topical therapies for metastatic breast cancer and associated pain.

Headquartered in San Francisco with principal offices in Las Vegas, London, Milan, and Dubai, US Capital is a full-service global private financial group with an established track record in corporate finance, asset management, and capital formation services. All securities are offered by the group through its FINRA-member, SEC-registered broker-dealer affiliate, US Capital Global Securities LLC.

“An estimated 2.5% of the US population has suffered from chronic wounds in 2021, a problem seriously compounded by antibiotic resistance,” stated Andira’s president and CEO, Dr. Dana Lambert, who received her Ph.D. in Pharmaceutical Sciences from the University of British Columbia, Vancouver. “Currently, consumers do not have access to convenient, all-in-one products that offer protection against these dangerous infections. Andira’s Matrix3 is a triple synergy, patent-pending silver-cannabinoid formula that fills this important gap, providing three-day protection against multi-drug resistant infections, including MRSA and Pseudomonas.”

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo by Tim Foster on Unsplash

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMarketsAndira PharmaceuticalsDana LambertpremiumUS CapitalUS Capital Global Securities LLC
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!